NEURAL CELL-ADHESION MOLECULE (CD56)-POSITIVE, T(8-21) ACUTE MYELOID-LEUKEMIA (AML, M-2) AND GRANULOCYTIC SARCOMA

被引:35
|
作者
KRISHNAN, K
ROSS, CW
ADAMS, PT
PEREIRA, A
ROTH, MS
机构
[1] Division of Hematology-Oncology, Department of Internal Medicine, Upjohn Center, Ann Arbor, 48109-0504, MI, 1310, E. Catherine Drive
关键词
T(8-21) AML; GRANULOCYTIC SARCOMA; CD56; ADHESION MOLECULE;
D O I
10.1007/BF01696563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 49-year-old man with t(8; 21) acute myeloid leukemia relapsed 8 months after successful induction chemotherapy with a paraspinal granulocytic sarcoma. There was no evidence of leukemia in the bone marrow at relapse. At initial presentation, the blasts co-expressed CD 15, CD 33, CD 34, CD 45, CD 19, and CD 56 (a neural cell-adhesion molecule). Expression of certain cell-adhesion molecules on leukemic blasts may determine a tendency to develop extramedullary relapse. The co-expression of CD 56 may have a role in the predisposition of t(8; 21) AML to develop GS.
引用
收藏
页码:321 / 323
页数:3
相关论文
共 50 条
  • [1] NEURAL CELL-ADHESION MOLECULE (CD56) EXPRESSION IS ASSOCIATED WITH FAB SUBTYPE, CYTOGENETICS AND SKIN INFILTRATION IN ACUTE MYELOID-LEUKEMIA (AML)
    SEYMOUR, JF
    PIERCE, SA
    KANTARJIAN, H
    KEATING, MJ
    ESTEY, EH
    BLOOD, 1993, 82 (10) : A126 - A126
  • [2] EPIDURAL GRANULOCYTIC SARCOMA IN ACUTE MYELOID-LEUKEMIA WITH 8-21 TRANSLOCATION
    WODZINSKI, MA
    COLLIN, R
    WINFIELD, DA
    DALTON, A
    LAWRENCE, ACK
    CANCER, 1988, 62 (07) : 1299 - 1300
  • [3] RECURRENT GRANULOCYTIC SARCOMA - AN UNUSUAL VARIATION OF ACUTE MYELOGENOUS LEUKEMIA ASSOCIATED WITH 8-21 CHROMOSOMAL TRANSLOCATION AND BLAST EXPRESSION OF THE NEURAL CELL-ADHESION MOLECULE
    BYRD, JC
    WEISS, RB
    CANCER, 1994, 73 (08) : 2107 - 2112
  • [4] MORPHOLOGY OF T(8-21) ACUTE MYELOID-LEUKEMIA MYELODYSPLASTIC SYNDROME (AML/MDS)
    HUTCHISON, R
    LAWRENCE, D
    MACCALLUM, J
    VARNEY, J
    DEHORITY, D
    WURSTERHILL, D
    BLOOMFIELD, C
    DAVEY, F
    LABORATORY INVESTIGATION, 1991, 64 (01) : A74 - A74
  • [5] Acute myeloid leukemia (AML) with CD56 expression - A very high incidence of CD56 expression in AML with t(8;21) in Taiwan.
    Hsiao, CH
    Tang, JL
    Yao, M
    Tsay, W
    Wang, CH
    Chen, YC
    Shen, MC
    Tien, HF
    BLOOD, 2000, 96 (11) : 190B - 191B
  • [6] INVESTIGATION OF KARYOTYPIC, MORPHOLOGIC AND CLINICAL-FEATURES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA BLAST CELLS EXPRESSING THE NEURAL CELL-ADHESION MOLECULE (CD56)
    SEYMOUR, JF
    PIERCE, SA
    KANTARJIAN, HM
    KEATING, MJ
    ESTEY, EH
    LEUKEMIA, 1994, 8 (05) : 823 - 826
  • [7] 2 NEW VARIANTS OF T(8-21) IN ACUTE MYELOID-LEUKEMIA
    MCCARTHY, O
    MORGAN, C
    GILLETT, A
    ROWELL, J
    MARTIN, N
    ROBERTS, A
    SEELEY, G
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 245 - 245
  • [8] Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia
    Sasca, Daniel
    Schueler, Andrea
    Szybinski, Jakub
    Kriege, Oliver
    Kunz, Kerstin
    Fehr, Eva Marie
    Haehnel, Patricia
    Gebhardt, Wolf Henning
    Reid, Gerge
    Theobald, Matthias
    Bullinger, Lars
    Kindler, Thomas
    BLOOD, 2015, 126 (23)
  • [9] TARGETING ABERRANT NCAM (NEURAL CELL ADHESION MOLECULE; CD56) EXPRESSION IN ACUTE MYELOID LEUKEMIA
    Sasca, D.
    Kriege, O.
    Kunz, K.
    Schueler, A.
    Szybinski, J.
    Fehr, E. M.
    Haehnel, P.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    HAEMATOLOGICA, 2015, 100 : 34 - 35
  • [10] Targeting aberrant NCAM (neural cell adhesion molecule; CD56) expression in acute myeloid leukemia
    Sasca, D.
    Schueler, A.
    Kriege, O.
    Kunz, K.
    Szybinski, J.
    Fehr, E-M
    Haehnel, P. S.
    Gebhardt, W. H.
    Reid, G.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    Oncology Research and Treatment, 2015, 38 : 8 - 8